{
  "id": 401,
  "text": "Clinically visible lesion 4.0 cm or less in greatest dimension</td></tr><tr><td>T1b2</td><td>IB2</td><td>Clinically visible lesion more than 4.0 cm in greatest dimension</td></tr><tr><td>T2</td><td>11</td><td>Cervical carcinoma invading beyond the uterus but not to the pelvic wall or</td></tr><tr><td>T2a</td><td>IIA</td><td>to lower third of the vagina Tumour without parametrial invasion</td></tr><tr><td>T2a1</td><td>IIA1</td><td>Clinically visible lesion 4.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Clinically visible lesion 4.0 cm or less in greatest dimension</td></tr><tr><td>T1b2</td><td>IB2</td><td>Clinically visible lesion more than 4.0 cm in greatest dimension</td></tr><tr><td>T2</td><td>11</td><td>Cervical carcinoma invading beyond the uterus but not to the pelvic wall or</td></tr><tr><td>T2a</td><td>IIA</td><td>to lower third of the vagina Tumour without parametrial invasion</td></tr>\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在宫颈癌的临床分期中，T1b2和T2a的病灶特征主要通过病灶大小及侵害范围来区分。T1b2期的病灶是指临床可见的病灶，其最大直径超过4.0厘米，而T2a期是指癌症已超越子宫侵害但尚未到达骨盆壁或下三分之一阴道，并且没有腹膜浸润的情况。T2a的病灶可见，但没有累及到腹膜间隙。总结来说，T1b2关注的是病灶的尺寸，而T2a则关注癌症的侵害范围。",
  "query": "**在宫颈癌的临床分期中，如何区分T1b2和T2a的病灶特征？**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **在宫颈癌的临床分期中，如何区分T1b2和T2a的病灶特征？**\n\n<reference text>: Clinically visible lesion 4.0 cm or less in greatest dimension</td></tr><tr><td>T1b2</td><td>IB2</td><td>Clinically visible lesion more than 4.0 cm in greatest dimension</td></tr><tr><td>T2</td><td>11</td><td>Cervical carcinoma invading beyond the uterus but not to the pelvic wall or</td></tr><tr><td>T2a</td><td>IIA</td><td>to lower third of the vagina Tumour without parametrial invasion</td></tr><tr><td>T2a1</td><td>IIA1</td><td>Clinically visible lesion 4.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在宫颈癌的临床分期中，T1b2和T2a的病灶特征主要通过病灶大小及侵害范围来区分。T1b2期的病灶是指临床可见的病灶，其最大直径超过4.0厘米，而T2a期是指癌症已超越子宫侵害但尚未到达骨盆壁或下三分之一阴道，并且没有腹膜浸润的情况。T2a的病灶可见，但没有累及到腹膜间隙。总结来说，T1b2关注的是病灶的尺寸，而T2a则关注癌症的侵害范围。"
}